Pathogenic Analysis of Two SLC22A5 Variants That Alter RNA Splicing in Patients with Primary Carnitine Deficiency
International Journal of Neonatal Screening · 16.03.2026 · 12 (1) · 17
DOI: 10.3390/ijns12010017 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 16.03.2026. Verfasst von Yiming Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Quanzhou Maternity and Children's Hospital, School of Medicine, Huaqiao University, Quanzhou 362000, China. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Joint Funds for the Innovation of Science and Technology, Fujian Province, Quanzhou Municipal Science and Technology Plan Project.
Abstract (Originalsprache)
Functional analysis of SLC22A5 variants can improve diagnostic accuracy in patients with primary carnitine deficiency (PCD). Herein, we performed a genetic analysis of three neonates with PCD. Two of the patients harbored a novel synonymous SLC22A5 variant that has not been previously reported, and the other patient harbored a classical splice site variant. The splicing patterns of the two SLC22A5 variants were evaluated using three in silico tools, and in vitro minigene analysis was performed to verify the impact of variants on RNA splicing mechanisms. All three in silico tools predicted that both SLC22A5 variants could alter normal RNA splicing. Functional studies using minigene assays demonstrated that the c.450C>T (p.F150=) leads to partial exon 2 skipping, and c.394-1G>A leads to intron 1 retention and exon 2 skipping. Intron 1 retention of 65 nucleotides and exon 2 skipping were confirmed by sequencing cDNA amplification products. These results, along with functional evidence, led to reclassification of c.450C>T (p.F150=) and c.394-1G>A as likely pathogenic and pathogenic, respectively. This is the first reported synonymous variant in the SLC22A5 gene that has been functionally validated to affect RNA splicing, thus enriching the variant spectrum of SLC22A5 and aiding accurate PCD diagnosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Quanzhou Maternity and Children's Hospital, School of Medicine, Huaqiao University, Quanzhou 362000, China.
- Center of Neonatal Disease Screening, Quanzhou Maternity and Children's Hospital, School of Medicine, Huaqiao University, Quanzhou 362000, China.
ORCID-Profile: Yiming Lin
Förderung
- Natural Science Foundation of Fujian Province
- Joint Funds for the Innovation of Science and Technology, Fujian Province
- Quanzhou Municipal Science and Technology Plan Project
Zitieren
APA
Lin, Y., Chen, Y., Lin, W., & Zheng, F. (2026). Pathogenic Analysis of Two SLC22A5 Variants That Alter RNA Splicing in Patients with Primary Carnitine Deficiency. International Journal of Neonatal Screening, 12(1), 17. https://doi.org/10.3390/ijns12010017
Vancouver
Lin Y, Chen Y, Lin W, Zheng F. Pathogenic Analysis of Two SLC22A5 Variants That Alter RNA Splicing in Patients with Primary Carnitine Deficiency. International Journal of Neonatal Screening. 2026;12(1):17. doi:10.3390/ijns12010017
BibTeX
@article{Lin2026,
author = {Lin, Yiming and Chen, Yanru and Lin, Weihua and Zheng, Faming},
title = {Pathogenic Analysis of Two SLC22A5 Variants That Alter RNA Splicing in Patients with Primary Carnitine Deficiency},
journal = {International Journal of Neonatal Screening},
year = {2026},
volume = {12},
number = {1},
pages = {17},
doi = {10.3390/ijns12010017}
}
EUVIMED